Serum Imatinib Levels Predict Gist Response

Serum Imatinib (Gleevec) Levels Predict GIST Response

GIST: Assessing Response to Imatinib Therapy

Side Effects Associated With Gleevec for GIST

Dr. Jerald Radich on Impact of Generic Imatinib in CML

Clinical Signs of Imatinib Sub-optimal Response or Failure

Mastering GIST treatment: Imatinib and other targeted therapy for gastrointestinal stromal tumors

Edusurg Clinics

Examining Kidney Toxicities of Sunitinib and Imatinib in Long Term GIST Therapy

The Life Raft Group

Update on the treatment of GIST

Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable GIST

Generic Imatinib: Gaining Perspective

The Life Raft Group

Dr. Joensuu Summarizes the Imatinib for High-Risk GIST Trial

Coming off Imatinib – Nic Puntis

Longer Adjuvant Imatinib Therapy Better in High-Risk GIST

MDedge: news and insights for busy physicians

Gastrointestinal Stromal Tumor (GIST) of the Stomach

Hassan Aziz, MD

Therapeutic strategy in GIST tumors

Spotlight on Testing: Imatinib Mesylate

ARUP Laboratories

No Differences in Molecular Relapse-Free Survival After Stopping Imatinib Treatment

Cancer Therapy Advisor

Dr. Kris Discusses the Imatinib GIST Clinical Trial

GIST Treatment: Durability of Response and Challenges

Dr. Joensuu Discusses Resistance to Imatinib in GIST